Literature DB >> 28050039

Impact of Crohn's Disease Duration on the Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis.

De-Jun Cui1, Xun Zhao1, Mei Hu1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28050039     DOI： 10.1038/ajg.2016.339

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  6 in total

1.  Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study.

Authors:  N Chalasani; A Baluyut; A Ismail; A Zaman; G Sood; R Ghalib; T M McCashland; K R Reddy; X Zervos; M A Anbari; H Hoen
Journal:  Hepatology       Date:  2000-01       Impact factor: 17.425

2.  ACG Clinical Guideline: Primary Sclerosing Cholangitis.

Authors:  Keith D Lindor; Kris V Kowdley; M Edwyn Harrison
Journal:  Am J Gastroenterol       Date:  2015-04-14       Impact factor: 10.864

3.  Primary sclerosing cholangitis and disease distribution in inflammatory bowel disease.

Authors:  Aoibhlinn O'Toole; Alaa Alakkari; Denise Keegan; Glen Doherty; Hugh Mulcahy; Diarmuid O'Donoghue
Journal:  Clin Gastroenterol Hepatol       Date:  2011-11-15       Impact factor: 11.382

4.  A unique clinical phenotype of primary sclerosing cholangitis associated with Crohn's disease.

Authors:  J S Halliday; J Djordjevic; M Lust; E L Culver; B Braden; S P L Travis; R W G Chapman
Journal:  J Crohns Colitis       Date:  2011-10-28       Impact factor: 9.071

5.  Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).

Authors:  Jesus M Banales; Vincenzo Cardinale; Guido Carpino; Marco Marzioni; Jesper B Andersen; Pietro Invernizzi; Guro E Lind; Trine Folseraas; Stuart J Forbes; Laura Fouassier; Andreas Geier; Diego F Calvisi; Joachim C Mertens; Michael Trauner; Antonio Benedetti; Luca Maroni; Javier Vaquero; Rocio I R Macias; Chiara Raggi; Maria J Perugorria; Eugenio Gaudio; Kirsten M Boberg; Jose J G Marin; Domenico Alvaro
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-04-20       Impact factor: 46.802

6.  Duration of Inflammatory Bowel Disease Is Associated With Increased Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis and IBD.

Authors:  Aliya F Gulamhusein; John E Eaton; James H Tabibian; Elizabeth J Atkinson; Brian D Juran; Konstantinos N Lazaridis
Journal:  Am J Gastroenterol       Date:  2016-03-22       Impact factor: 10.864
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.